INTERNATIONAL PATENT: LUCY THERAPEUTICS, INC. FILES APPLICATION FOR "ADENOSINE LIGANDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS OR CHRONIC HEART FAILURE"

GENEVA, Feb. 26 -- LUCY THERAPEUTICS, INC. (21 Hickory DriveSuite 2BWaltham, Massachusetts 02451) filed a patent application (PCT/US2024/042359) for "ADENOSINE LIGANDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS OR CHRONIC HEART FAILURE" on Aug 14, 2024. With publication no. WO/2025/038781, the details related to the patent application was published on Feb 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DOLLER, Dario (c/o Lucy Therapeutics, Inc.21 Hickory DriveSuite 2BWaltham, Massachusetts 02451), LI, Guiying (c/o Lucy Therapeutics, Inc.21 Hickory DriveSuite 2BWaltham, Massachusetts 024...